Alpine Immune Sciences Inc (NASDAQ:ALPN)

2.81
BATS BZX Real-Time Price
As of 11:43am ET
 -0.245 / -8.03%
Today’s Change
2.25
Today|||52-Week Range
8.24
-23.78%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$48.3M

Company Description

Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA.

Contact Information

Alpine Immune Sciences, Inc.
201 Elliott Avenue West
Seattle Washington 98119
P:(206) 788-4545
Investor Relations:

Employees

Shareholders

Individual stakeholders53.61%
Other institutional31.12%
Mutual fund holders1.84%

Top Executives

There are no executives to display.